Home » Evotec, Dow AgroSciences Enter Proteomics Service Deal

Evotec, Dow AgroSciences Enter Proteomics Service Deal

Jul 09, 2013
|
staff reporter

NEW YORK (GenomeWeb News) – Evotec today announced a collaboration to support the development of compounds in development at Dow AgroSciences.

As part of the deal, Evotec will provide its quantitative chemical proteomics services to "de-convolute phenotypic screening results" obtained by Dow AgroSciences, a wholly owned subsidiary of Dow Chemical.

Financial and other terms were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Here We Are Again

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

In the Pink

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

All Tied Up in a Bow

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

This Week in PNAS

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

What's Popular?

In Proteomics & Protein Research

  1. Pan-Cancer Mutation Study Identifies Protein Kinases Key to Tumor Suppression

    Premium

  2. Freenome, Biognosys Partner on Early Cancer Detection

  3. Copenhagen Team IDs Protein Complex Key to DNA Damage Repair

    Premium

  4. Top Down Proteomics Identifies Protein-Level Effects of KRAS Mutations in Colorectal Cancer

    Premium

  5. Waters Q1 Revenues Up 7 Percent

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.